The Feasibility and Safety of the Glean Urodynamics System: The Modern Urodynamics System Efficacy Study

<b><i>Purpose:</i></b> Urodynamics is used to diagnose lower urinary tract dysfunction; however, conventional urodynamics results often poorly correlate to patient symptoms because of the nonphysiological nature of the test. The Glean<sup>TM</sup> Urodynamics System is a novel, wireless, catheter-free ambulatory urodynamics system that allows clinicians to study lower urinary tract dysfunction in a more physiological manner. The objective of this study was to evaluate the feasibility, efficacy, and safety of the Glean Urodynamics System for use in clinic. <b><i>Materials and Methods:</i></b> This prospective, single-arm, multicenter interventional trial enrolled adults with lower urinary tract dysfunction. Participants underwent conventional urodynamics per standard of care followed by ambulatory urodynamics using the intravesical Glean bladder sensor. After the removal of the Glean sensor, participants completed comfort and preference questionnaires. Participants were followed up within 7-14 days to assess the incidence of adverse events. <b><i>Results:</i></b> Thirty-eight participants were enrolled. Glean sensor insertion was attempted in 33 participants and successful in 32 (97.0%). The median sensor insertion time was 33.62 seconds (range: 12.32-256). The Glean Urodynamics System recorded vesical pressure, and all 32 participants were able to void with the sensor indwelling. Median sensor removal time was 5.71 seconds (range: 0.79-22.15). There were 14 adverse events in 12 participants, of which 7 events (in 7 participants) were attributed to the Glean Urodynamics System. There were no serious adverse events. Overall participant feedback on the Glean Urodynamics System was positive, and clinicians reported it was easy to use. <b><i>Conclusions:</i></b> The Glean Urodynamics System is a feasible, efficacious, safe, and well-tolerated device that enables ambulatory urodynamics with physiological bladder filling and without catheters impeding lower urinary tract function.

Authors

Institutions

Publication Details

Journal
Journal of Endourology
Published
2025-05-02
DOI
https://doi.org/10.1089/end.2025.0270
Citations
4
Primary Topic
Pelvic floor disorders treatments
Type
article
Field-Weighted Citation Impact
6.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Feasibility and Safety of the Glean Urodynamics System: The Modern Urodynamics System Efficacy Study

Hanson Zhao, Jason M. Kim, Keith Xavier, Tracy Cannon‐Smith et al.
4 citations
Journal of Endourology
Pelvic floor disorders treatments
6.67
article

The Feasibility and Safety of the Glean Urodynamics System: The Modern Urodynamics System Efficacy Study

Hanson Zhao, Jason M. Kim, Keith Xavier, Tracy Cannon‐Smith, Arshia Aalami Harandi, Sreenivas Vemulapalli, Nemi Shah, Taylor Vaughan
article en
4 citations

Abstract

<b><i>Purpose:</i></b> Urodynamics is used to diagnose lower urinary tract dysfunction; however, conventional urodynamics results often poorly correlate to patient symptoms because of the nonphysiological nature of the test. The Glean<sup>TM</sup> Urodynamics System is a novel, wireless, catheter-free ambulatory urodynamics system that allows clinicians to study lower urinary tract dysfunction in a more physiological manner. The objective of this study was to evaluate the feasibility, efficacy, and safety of the Glean Urodynamics System for use in clinic. <b><i>Materials and Methods:</i></b> This prospective, single-arm, multicenter interventional trial enrolled adults with lower urinary tract dysfunction. Participants underwent conventional urodynamics per standard of care followed by ambulatory urodynamics using the intravesical Glean bladder sensor. After the removal of the Glean sensor, participants completed comfort and preference questionnaires. Participants were followed up within 7-14 days to assess the incidence of adverse events. <b><i>Results:</i></b> Thirty-eight participants were enrolled. Glean sensor insertion was attempted in 33 participants and successful in 32 (97.0%). The median sensor insertion time was 33.62 seconds (range: 12.32-256). The Glean Urodynamics System recorded vesical pressure, and all 32 participants were able to void with the sensor indwelling. Median sensor removal time was 5.71 seconds (range: 0.79-22.15). There were 14 adverse events in 12 participants, of which 7 events (in 7 participants) were attributed to the Glean Urodynamics System. There were no serious adverse events. Overall participant feedback on the Glean Urodynamics System was positive, and clinicians reported it was easy to use. <b><i>Conclusions:</i></b> The Glean Urodynamics System is a feasible, efficacious, safe, and well-tolerated device that enables ambulatory urodynamics with physiological bladder filling and without catheters impeding lower urinary tract function.

Journal of EndourologyVol. 39(6)
Hoag Memorial Hospital Presbyterian (US), Palmetto Pharmaceuticals (United States) (US), Stony Brook Medicine (US), Urology Associates of North Texas (US), Valley Medical Center (US)
Openalex Percentile: Top 3%
Pelvic floor disorders treatments
6.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.